THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS | Rudakova | Current Pediatrics

Current Pediatrics
Voprosy sovremennoj pediatrii

ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)

eng | рус

Preview

Current Pediatrics

Advanced search

Archives

Download this PDF file

For citations:

Rudakova A.V., Babachenko I.V., Rovnyi V.B., Uskov A.N., Lobzin Yu.V. THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS. Current Pediatrics. 2012;11(4):142-147. (In Russ.) https://doi.org/10.15690/vsp.v11i4.374

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)

Editor-in-Chief

Baranov A.A.

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Article Tools

Abstract

Print this article

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. V. Rudakova
Scientific Research Institute of Children Infections of the Federal Medical-Biological Agency, St. Petersburg
Russian Federation

Alla Rudakova, Doctor of Pharmaceutical Sciences, senior research associate of the department of organization of medical care

I. V. Babachenko
Scientific Research Institute of Children Infections of the Federal Medical-Biological Agency, St. Petersburg
Russian Federation

V. B. Rovnyi
Scientific Research Institute of Children Infections of the Federal Medical-Biological Agency, St. Petersburg
Russian Federation

A. N. Uskov
Scientific Research Institute of Children Infections of the Federal Medical-Biological Agency, St. Petersburg
Russian Federation

Yu. V. Lobzin
Scientific Research Institute of Children Infections of the Federal Medical-Biological Agency, St. Petersburg
Russian Federation

Notifications